Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina M Moloney

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2021
Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker researchChristina M Moloney, Val J Lowe, Melissa E Murray
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 3, 2022
Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brainChristina M Moloney, Sydney A Labuzan, Julia E Crook, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
The Neurofibrillary Tangle Maturity Scale: A Novel Framework for Tangle Pathology Evaluation in Alzheimer's DiseaseChristina M Moloney, Matthew H Rutledge, Sydney A Labuzan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisBaayla D C Boon, Yoav D Piura, Christina M Moloney, et al.
Alzheimer'S Research & Therapy|October 15, 2025
Association between antemortem plasma and structural MRI biomarkers and postmortem tau pathology in the Mayo Clinic Study of AgingMingzhao Hu, Christina M Moloney, Scott A Przybelski, et al.
Neurobiology of Aging|August 11, 2022
Association of plasma biomarkers of amyloid and neurodegeneration with cerebrovascular disease and Alzheimer's diseaseJonathan Graff-Radford, Michelle M Mielke, Ekaterina I Hofrenning, et al.
The Journal of Prevention of Alzheimer'S Disease|June 12, 2025
Impact of cardiovascular risk factors on plasma biomarkers in prediction of Alzheimer's and cerebrovascular neuropathologyCamilo Bermudez, Jeremy A Syrjanen, Nikki H Stricker, et al.
Acta Neuropathologica|March 14, 2025
High resolution autoradiography of [<sup>18</sup>F]MK-6240 and [<sup>18</sup>F]Flortaucipir shows similar neurofibrillary tangle binding patterns preferentially recognizing middling neurofibrillary tangle maturitySujala Ghatamaneni, Courtney Coleman, Ian Shin, et al.
Molecular Neurodegeneration|December 27, 2022
Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levelsMelissa E Murray, Christina M Moloney, Naomi Kouri, et al.
The Lancet. Neurology|October 18, 2025
Neuropathological changes and amyloid-related imaging abnormalities in Alzheimer's disease treated with aducanumab versus untreated: a retrospective case-control studyBaayla D C Boon, Yoav D Piura, Christina M Moloney, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2021
Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker researchChristina M Moloney, Val J Lowe, Melissa E Murray
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 3, 2022
Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brainChristina M Moloney, Sydney A Labuzan, Julia E Crook, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
The Neurofibrillary Tangle Maturity Scale: A Novel Framework for Tangle Pathology Evaluation in Alzheimer's DiseaseChristina M Moloney, Matthew H Rutledge, Sydney A Labuzan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisBaayla D C Boon, Yoav D Piura, Christina M Moloney, et al.
Alzheimer'S Research & Therapy|October 15, 2025
Association between antemortem plasma and structural MRI biomarkers and postmortem tau pathology in the Mayo Clinic Study of AgingMingzhao Hu, Christina M Moloney, Scott A Przybelski, et al.
Neurobiology of Aging|August 11, 2022
Association of plasma biomarkers of amyloid and neurodegeneration with cerebrovascular disease and Alzheimer's diseaseJonathan Graff-Radford, Michelle M Mielke, Ekaterina I Hofrenning, et al.
The Journal of Prevention of Alzheimer'S Disease|June 12, 2025
Impact of cardiovascular risk factors on plasma biomarkers in prediction of Alzheimer's and cerebrovascular neuropathologyCamilo Bermudez, Jeremy A Syrjanen, Nikki H Stricker, et al.
Acta Neuropathologica|March 14, 2025
High resolution autoradiography of [<sup>18</sup>F]MK-6240 and [<sup>18</sup>F]Flortaucipir shows similar neurofibrillary tangle binding patterns preferentially recognizing middling neurofibrillary tangle maturitySujala Ghatamaneni, Courtney Coleman, Ian Shin, et al.
Molecular Neurodegeneration|December 27, 2022
Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levelsMelissa E Murray, Christina M Moloney, Naomi Kouri, et al.
The Lancet. Neurology|October 18, 2025
Neuropathological changes and amyloid-related imaging abnormalities in Alzheimer's disease treated with aducanumab versus untreated: a retrospective case-control studyBaayla D C Boon, Yoav D Piura, Christina M Moloney, et al.
Pageof 2